(NASDAQ: ASRT) Assertio Holdings's forecast annual revenue growth rate of 13.12% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.34%.
Assertio Holdings's revenue in 2026 is $102,156,000.On average, 6 Wall Street analysts forecast ASRT's revenue for 2026 to be $754,007,162, with the lowest ASRT revenue forecast at $717,108,115, and the highest ASRT revenue forecast at $791,875,537. On average, 5 Wall Street analysts forecast ASRT's revenue for 2027 to be $834,655,169, with the lowest ASRT revenue forecast at $767,836,228, and the highest ASRT revenue forecast at $895,658,148.
In 2028, ASRT is forecast to generate $969,391,622 in revenue, with the lowest revenue forecast at $931,394,003 and the highest revenue forecast at $997,889,836.